These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1562118)

  • 41. Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy.
    Canada AT; Lesko LJ; Haffajee CI; Johnson B; Asdourian GK
    Drug Intell Clin Pharm; 1983 Feb; 17(2):100-4. PubMed ID: 6337802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amiodarone treatment of critical arrhythmias in children and young adults.
    Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM
    J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Practical follow-up guidelines for patients treated with amiodarone.
    Podrid PJ
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I10-6. PubMed ID: 3078154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
    J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
    Kimura M; Ogawa H; Wakeyama T; Takaki A; Iwami T; Hadano Y; Miyazaki Y; Shimizu A; Matsuzaki M
    J Cardiol; 2006 Dec; 48(6):359-65. PubMed ID: 17243631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up].
    Di Pede F; Raviele A; Gasparini G; Caprioglio F; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1990 Sep; 20(9):819-27. PubMed ID: 2079183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate.
    Winters SL; Sachs RG; Curwin JH
    Chest; 1997 May; 111(5):1454-7. PubMed ID: 9149614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia].
    Scanavacca MI; Sosa EA; Lee JH; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1990 Jun; 54(6):367-71. PubMed ID: 2288524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiologic effects of amiodarone in tachyarrhythmias.
    Liu PH; Lin CC; Ko GC; Wang DJ; Shieh SM; Sung PK
    Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):759-75. PubMed ID: 3864917
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amiodarone. Therapeutics and guidelines.
    Frei J
    Prog Cardiovasc Nurs; 1989; 4(4):113-8. PubMed ID: 2602355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
    Mostow ND; Vrobel TR; Rakita L
    Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence-based analysis of amiodarone efficacy and safety.
    Connolly SJ
    Circulation; 1999 Nov; 100(19):2025-34. PubMed ID: 10556230
    [No Abstract]   [Full Text] [Related]  

  • 56. [Antiarrhythmic effect and side effects of amiodarone].
    Weber H; Weissel M; Haddad R; Scheibelhofer W; Konrad K; Mlczoch J; Probst P; Mainitz M
    Wien Klin Wochenschr; 1984 Sep; 96(18):685-96. PubMed ID: 6523885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study.
    Moran JL; Gallagher J; Peake SL; Cunningham DN; Salagaras M; Leppard P
    Crit Care Med; 1995 Nov; 23(11):1816-24. PubMed ID: 7587256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.
    Mooss AN; Mohiuddin SM; Hee TT; Esterbrooks DJ; Hilleman DE; Rovang KS; Sketch MH
    Am J Cardiol; 1990 Mar; 65(9):609-14. PubMed ID: 2178383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.